aluates Reports

$ 0.0

Automative

Global Artemisinin Combination Therapy Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-5U14690

Global Artemisinin Combination Therapy Market Insights Forecast to 2029

BUY CHAPTERS

Global Artemisinin Combination Therapy Market Research Report 2025

Code: QYRE-Auto-5U14690

Report

August 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

KPC Pharmaceuticals

Shanghai Fosun Pharmaceutical Industrial Development

Sanofi

Desano Holdings

Calyx Chemicals and Pharmaceuticals

Mylan NV

Novartis

Denk Pharma

Hovid Berhad

Ipca Laboratories

Cipla Ltd

Aspen Pharmacare Holdings

Ajanta Pharma

Guilin Pharmaceuticals

Artemisinin Combination Therapy Market Size

The global market for Artemisinin Combination Therapy was valued at US$ 393 million in the year 2024 and is projected to reach a revised size of US$ 543 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Artemisinin Combination Therapy Market

Artemisinin Combination Therapy is recommended for thetreatment of P. falciparum malaria. Fast acting artemisinin-based compounds arecombined with a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether.

North American market for Artemisinin Combination Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Artemisinin Combination Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Artemisinin Combination Therapy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Artemisinin Combination Therapy include KPC Pharmaceuticals, Shanghai Fosun Pharmaceutical Industrial Development, Sanofi, Desano Holdings, Calyx Chemicals and Pharmaceuticals, Mylan, Novartis, Denk Pharma, Hovid Berhad, Ipca Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Artemisinin Combination Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin Combination Therapy.

The Artemisinin Combination Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artemisinin Combination Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Artemisinin Combination Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Artemisinin Combination Therapy Market Report

Report Metric	Details
Report Name	Artemisinin Combination Therapy Market
Accounted market size in year	US$ 393 million
Forecasted market size in 2031	US$ 543 million
CAGR	4.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Artemether+Lumefantrine Artesunate+Amodiaquine Dihydroartemisinin+Piperaquine Artesunate+Mefloquine Artesunate+Sulfadoxine-Pyrimethamine Pyronaridine-Artesunate Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	KPC Pharmaceuticals, Shanghai Fosun Pharmaceutical Industrial Development, Sanofi, Desano Holdings, Calyx Chemicals and Pharmaceuticals, Mylan, Novartis, Denk Pharma, Hovid Berhad, Ipca Laboratories, Cipla, Aspen Pharmacare Holdings, Ajanta Pharma, Guilin Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artemisinin Combination Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Artemisinin Combination Therapy Market growing?

Ans: The Artemisinin Combination Therapy Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Artemisinin Combination Therapy Market size in 2031?

Ans: The Artemisinin Combination Therapy Market size in 2031 will be US$ 543 million.

Who are the main players in the Artemisinin Combination Therapy Market report?

Ans: The main players in the Artemisinin Combination Therapy Market are KPC Pharmaceuticals, Shanghai Fosun Pharmaceutical Industrial Development, Sanofi, Desano Holdings, Calyx Chemicals and Pharmaceuticals, Mylan, Novartis, Denk Pharma, Hovid Berhad, Ipca Laboratories, Cipla, Aspen Pharmacare Holdings, Ajanta Pharma, Guilin Pharmaceuticals

What are the Application segmentation covered in the Artemisinin Combination Therapy Market report?

Ans: The Applications covered in the Artemisinin Combination Therapy Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Artemisinin Combination Therapy Market report?

Ans: The Types covered in the Artemisinin Combination Therapy Market report are Artemether+Lumefantrine, Artesunate+Amodiaquine, Dihydroartemisinin+Piperaquine, Artesunate+Mefloquine, Artesunate+Sulfadoxine-Pyrimethamine, Pyronaridine-Artesunate, Other

Recommended Reports

Combination Therapy Markets

Infectious Disease Treatments

Chronic Disease & Cancer Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Artemether+Lumefantrine

1.2.3 Artesunate+Amodiaquine

1.2.4 Dihydroartemisinin+Piperaquine

1.2.5 Artesunate+Mefloquine

1.2.6 Artesunate+Sulfadoxine-Pyrimethamine

1.2.7 Pyronaridine-Artesunate

1.2.8 Other

1.3 Market by Application

1.3.1 Global Artemisinin Combination Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Artemisinin Combination Therapy Market Perspective (2020-2031)

2.2 Global Artemisinin Combination Therapy Growth Trends by Region

2.2.1 Global Artemisinin Combination Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Artemisinin Combination Therapy Historic Market Size by Region (2020-2025)

2.2.3 Artemisinin Combination Therapy Forecasted Market Size by Region (2026-2031)

2.3 Artemisinin Combination Therapy Market Dynamics

2.3.1 Artemisinin Combination Therapy Industry Trends

2.3.2 Artemisinin Combination Therapy Market Drivers

2.3.3 Artemisinin Combination Therapy Market Challenges

2.3.4 Artemisinin Combination Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Artemisinin Combination Therapy Players by Revenue

3.1.1 Global Top Artemisinin Combination Therapy Players by Revenue (2020-2025)

3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Artemisinin Combination Therapy Revenue

3.4 Global Artemisinin Combination Therapy Market Concentration Ratio

3.4.1 Global Artemisinin Combination Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Artemisinin Combination Therapy Revenue in 2024

3.5 Global Key Players of Artemisinin Combination Therapy Head office and Area Served

3.6 Global Key Players of Artemisinin Combination Therapy, Product and Application

3.7 Global Key Players of Artemisinin Combination Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Artemisinin Combination Therapy Breakdown Data by Type

4.1 Global Artemisinin Combination Therapy Historic Market Size by Type (2020-2025)

4.2 Global Artemisinin Combination Therapy Forecasted Market Size by Type (2026-2031)

5 Artemisinin Combination Therapy Breakdown Data by Application

5.1 Global Artemisinin Combination Therapy Historic Market Size by Application (2020-2025)

5.2 Global Artemisinin Combination Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Artemisinin Combination Therapy Market Size (2020-2031)

6.2 North America Artemisinin Combination Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Artemisinin Combination Therapy Market Size by Country (2020-2025)

6.4 North America Artemisinin Combination Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Artemisinin Combination Therapy Market Size (2020-2031)

7.2 Europe Artemisinin Combination Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Artemisinin Combination Therapy Market Size by Country (2020-2025)

7.4 Europe Artemisinin Combination Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Artemisinin Combination Therapy Market Size (2020-2031)

8.2 Asia-Pacific Artemisinin Combination Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Artemisinin Combination Therapy Market Size (2020-2031)

9.2 Latin America Artemisinin Combination Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Artemisinin Combination Therapy Market Size by Country (2020-2025)

9.4 Latin America Artemisinin Combination Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Artemisinin Combination Therapy Market Size (2020-2031)

10.2 Middle East & Africa Artemisinin Combination Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 KPC Pharmaceuticals

11.1.1 KPC Pharmaceuticals Company Details

11.1.2 KPC Pharmaceuticals Business Overview

11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Introduction

11.1.4 KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.1.5 KPC Pharmaceuticals Recent Development

11.2 Shanghai Fosun Pharmaceutical Industrial Development

11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Details

11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Business Overview

11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Introduction

11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Artemisinin Combination Therapy Introduction

11.3.4 Sanofi Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Desano Holdings

11.4.1 Desano Holdings Company Details

11.4.2 Desano Holdings Business Overview

11.4.3 Desano Holdings Artemisinin Combination Therapy Introduction

11.4.4 Desano Holdings Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.4.5 Desano Holdings Recent Development

11.5 Calyx Chemicals and Pharmaceuticals

11.5.1 Calyx Chemicals and Pharmaceuticals Company Details

11.5.2 Calyx Chemicals and Pharmaceuticals Business Overview

11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Introduction

11.5.4 Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.5.5 Calyx Chemicals and Pharmaceuticals Recent Development

11.6 Mylan

11.6.1 Mylan Company Details

11.6.2 Mylan Business Overview

11.6.3 Mylan Artemisinin Combination Therapy Introduction

11.6.4 Mylan Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.6.5 Mylan Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Artemisinin Combination Therapy Introduction

11.7.4 Novartis Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 Denk Pharma

11.8.1 Denk Pharma Company Details

11.8.2 Denk Pharma Business Overview

11.8.3 Denk Pharma Artemisinin Combination Therapy Introduction

11.8.4 Denk Pharma Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.8.5 Denk Pharma Recent Development

11.9 Hovid Berhad

11.9.1 Hovid Berhad Company Details

11.9.2 Hovid Berhad Business Overview

11.9.3 Hovid Berhad Artemisinin Combination Therapy Introduction

11.9.4 Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.9.5 Hovid Berhad Recent Development

11.10 Ipca Laboratories

11.10.1 Ipca Laboratories Company Details

11.10.2 Ipca Laboratories Business Overview

11.10.3 Ipca Laboratories Artemisinin Combination Therapy Introduction

11.10.4 Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.10.5 Ipca Laboratories Recent Development

11.11 Cipla

11.11.1 Cipla Company Details

11.11.2 Cipla Business Overview

11.11.3 Cipla Artemisinin Combination Therapy Introduction

11.11.4 Cipla Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.11.5 Cipla Recent Development

11.12 Aspen Pharmacare Holdings

11.12.1 Aspen Pharmacare Holdings Company Details

11.12.2 Aspen Pharmacare Holdings Business Overview

11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Introduction

11.12.4 Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.12.5 Aspen Pharmacare Holdings Recent Development

11.13 Ajanta Pharma

11.13.1 Ajanta Pharma Company Details

11.13.2 Ajanta Pharma Business Overview

11.13.3 Ajanta Pharma Artemisinin Combination Therapy Introduction

11.13.4 Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.13.5 Ajanta Pharma Recent Development

11.14 Guilin Pharmaceuticals

11.14.1 Guilin Pharmaceuticals Company Details

11.14.2 Guilin Pharmaceuticals Business Overview

11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Introduction

11.14.4 Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2020-2025)

11.14.5 Guilin Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

KPC Pharmaceuticals

Shanghai Fosun Pharmaceutical Industrial Development

Sanofi

Desano Holdings

Calyx Chemicals and Pharmaceuticals

Mylan NV

Novartis

Denk Pharma

Hovid Berhad

Ipca Laboratories

Cipla Ltd

Aspen Pharmacare Holdings

Ajanta Pharma

Guilin Pharmaceuticals

List of Tables

Table 1. Global Artemisinin Combination Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Artemether+Lumefantrine

Table 3. Key Players of Artesunate+Amodiaquine

Table 4. Key Players of Dihydroartemisinin+Piperaquine

Table 5. Key Players of Artesunate+Mefloquine

Table 6. Key Players of Artesunate+Sulfadoxine-Pyrimethamine

Table 7. Key Players of Pyronaridine-Artesunate

Table 8. Key Players of Other

Table 9. Global Artemisinin Combination Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Artemisinin Combination Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Artemisinin Combination Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Artemisinin Combination Therapy Market Share by Region (2020-2025)

Table 13. Global Artemisinin Combination Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Artemisinin Combination Therapy Market Share by Region (2026-2031)

Table 15. Artemisinin Combination Therapy Market Trends

Table 16. Artemisinin Combination Therapy Market Drivers

Table 17. Artemisinin Combination Therapy Market Challenges

Table 18. Artemisinin Combination Therapy Market Restraints

Table 19. Global Artemisinin Combination Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Artemisinin Combination Therapy Market Share by Players (2020-2025)

Table 21. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Combination Therapy as of 2024)

Table 22. Ranking of Global Top Artemisinin Combination Therapy Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Artemisinin Combination Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Artemisinin Combination Therapy, Headquarters and Area Served

Table 25. Global Key Players of Artemisinin Combination Therapy, Product and Application

Table 26. Global Key Players of Artemisinin Combination Therapy, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Artemisinin Combination Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Artemisinin Combination Therapy Revenue Market Share by Type (2020-2025)

Table 30. Global Artemisinin Combination Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Artemisinin Combination Therapy Revenue Market Share by Type (2026-2031)

Table 32. Global Artemisinin Combination Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Artemisinin Combination Therapy Revenue Market Share by Application (2020-2025)

Table 34. Global Artemisinin Combination Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Artemisinin Combination Therapy Revenue Market Share by Application (2026-2031)

Table 36. North America Artemisinin Combination Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Artemisinin Combination Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Artemisinin Combination Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Artemisinin Combination Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Artemisinin Combination Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Artemisinin Combination Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Artemisinin Combination Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Artemisinin Combination Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Artemisinin Combination Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Artemisinin Combination Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Artemisinin Combination Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 51. KPC Pharmaceuticals Company Details

Table 52. KPC Pharmaceuticals Business Overview

Table 53. KPC Pharmaceuticals Artemisinin Combination Therapy Product

Table 54. KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 55. KPC Pharmaceuticals Recent Development

Table 56. Shanghai Fosun Pharmaceutical Industrial Development Company Details

Table 57. Shanghai Fosun Pharmaceutical Industrial Development Business Overview

Table 58. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product

Table 59. Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 60. Shanghai Fosun Pharmaceutical Industrial Development Recent Development

Table 61. Sanofi Company Details

Table 62. Sanofi Business Overview

Table 63. Sanofi Artemisinin Combination Therapy Product

Table 64. Sanofi Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 65. Sanofi Recent Development

Table 66. Desano Holdings Company Details

Table 67. Desano Holdings Business Overview

Table 68. Desano Holdings Artemisinin Combination Therapy Product

Table 69. Desano Holdings Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 70. Desano Holdings Recent Development

Table 71. Calyx Chemicals and Pharmaceuticals Company Details

Table 72. Calyx Chemicals and Pharmaceuticals Business Overview

Table 73. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product

Table 74. Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 75. Calyx Chemicals and Pharmaceuticals Recent Development

Table 76. Mylan Company Details

Table 77. Mylan Business Overview

Table 78. Mylan Artemisinin Combination Therapy Product

Table 79. Mylan Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 80. Mylan Recent Development

Table 81. Novartis Company Details

Table 82. Novartis Business Overview

Table 83. Novartis Artemisinin Combination Therapy Product

Table 84. Novartis Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 85. Novartis Recent Development

Table 86. Denk Pharma Company Details

Table 87. Denk Pharma Business Overview

Table 88. Denk Pharma Artemisinin Combination Therapy Product

Table 89. Denk Pharma Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 90. Denk Pharma Recent Development

Table 91. Hovid Berhad Company Details

Table 92. Hovid Berhad Business Overview

Table 93. Hovid Berhad Artemisinin Combination Therapy Product

Table 94. Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 95. Hovid Berhad Recent Development

Table 96. Ipca Laboratories Company Details

Table 97. Ipca Laboratories Business Overview

Table 98. Ipca Laboratories Artemisinin Combination Therapy Product

Table 99. Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 100. Ipca Laboratories Recent Development

Table 101. Cipla Company Details

Table 102. Cipla Business Overview

Table 103. Cipla Artemisinin Combination Therapy Product

Table 104. Cipla Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 105. Cipla Recent Development

Table 106. Aspen Pharmacare Holdings Company Details

Table 107. Aspen Pharmacare Holdings Business Overview

Table 108. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product

Table 109. Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 110. Aspen Pharmacare Holdings Recent Development

Table 111. Ajanta Pharma Company Details

Table 112. Ajanta Pharma Business Overview

Table 113. Ajanta Pharma Artemisinin Combination Therapy Product

Table 114. Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 115. Ajanta Pharma Recent Development

Table 116. Guilin Pharmaceuticals Company Details

Table 117. Guilin Pharmaceuticals Business Overview

Table 118. Guilin Pharmaceuticals Artemisinin Combination Therapy Product

Table 119. Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2020-2025) & (US$ Million)

Table 120. Guilin Pharmaceuticals Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Artemisinin Combination Therapy Picture

Figure 2. Global Artemisinin Combination Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Artemisinin Combination Therapy Market Share by Type: 2024 VS 2031

Figure 4. Artemether+Lumefantrine Features

Figure 5. Artesunate+Amodiaquine Features

Figure 6. Dihydroartemisinin+Piperaquine Features

Figure 7. Artesunate+Mefloquine Features

Figure 8. Artesunate+Sulfadoxine-Pyrimethamine Features

Figure 9. Pyronaridine-Artesunate Features

Figure 10. Other Features

Figure 11. Global Artemisinin Combination Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Artemisinin Combination Therapy Market Share by Application: 2024 VS 2031

Figure 13. Hospital Case Studies

Figure 14. Clinic Case Studies

Figure 15. Other Case Studies

Figure 16. Artemisinin Combination Therapy Report Years Considered

Figure 17. Global Artemisinin Combination Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Artemisinin Combination Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Artemisinin Combination Therapy Market Share by Region: 2024 VS 2031

Figure 20. Global Artemisinin Combination Therapy Market Share by Players in 2024

Figure 21. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Combination Therapy as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Artemisinin Combination Therapy Revenue in 2024

Figure 23. North America Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Artemisinin Combination Therapy Market Share by Country (2020-2031)

Figure 25. United States Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Artemisinin Combination Therapy Market Share by Country (2020-2031)

Figure 29. Germany Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Artemisinin Combination Therapy Market Share by Region (2020-2031)

Figure 37. China Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Artemisinin Combination Therapy Market Share by Country (2020-2031)

Figure 45. Mexico Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Artemisinin Combination Therapy Market Share by Country (2020-2031)

Figure 49. Turkey Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Artemisinin Combination Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. KPC Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 53. Shanghai Fosun Pharmaceutical Industrial Development Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 54. Sanofi Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 55. Desano Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 56. Calyx Chemicals and Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 57. Mylan Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 58. Novartis Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 59. Denk Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 60. Hovid Berhad Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 61. Ipca Laboratories Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 62. Cipla Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 63. Aspen Pharmacare Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 64. Ajanta Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 65. Guilin Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Compound Artemether Tablets Market Research Report 2024

Artesunate Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artesunate Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artemisinin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Dihydroartemisinin Market Research Report 2025

Artesunate Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artemisinin Antimalarial Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artesunate Used for Malaria Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artemether Market Research Report 2025

Global Artesunate Tablet Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Artemisinin Derivatives Market Research Report 2025

Global Sulfadoxine Market Insights Forecast to 2030

Artemisinine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artemether Lumefantrine Tablets Market Research Report 2024

Global Artesunate API Market Research Report 2025

Global Dihydroartemisinin Tablets Market Research Report 2024

Malaria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artemisinin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Artemether Drugs Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions